查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1403474

2030 年临床试验物流市场预测：按阶段、服务类型、治疗领域、应用、最终用户和地区进行的全球分析

Clinical Trial Supply & Logistics Market Forecasts to 2030 - Global Analysis By Phase, By Service Type, By Therapeutic Area, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2023 年全球临床试验供应物流市场规模为 39 亿美元，预计在预测期内将以 9.5% 的复合年增长率成长，并在 2030 年达到 73 亿美元。

临床试验物流(CTSL) 是一个专业领域，可确保临床研究所需的药物、设备和其他关键材料的高效和安全运输。业务包括库存管理、包装、运输、清关和温度控制，以确保及时交付到世界各地的临床试验地点。 CTSL 促进临床试验并促进新药和治疗方法的开发。

临床试验需求增加

需求的增加导致临床试验供应物流（CTSL）市场的蓬勃发展。随着越来越多的临床试验进行，安全运输、准确的库存管理以及对温度敏感药物等材料的专业处理至关重要。 CTSL 提供者正在加紧努力，透过投资技术、扩大其全球足迹以及为个人化医疗和病人参与提供客製化解决方案来满足这一需求。因此，临床试验的蓬勃发展直接推动了CTSL市场的成长和创新。

温度敏感产品

临床试验通常涉及对温度敏感的药物、疫苗和生物样本的运输和储存，这些样本需要特定的受控条件来保持功效和完整性。挑战在于确保这些产品从製造到最终交付的整个供应链始终保持在建议的温度范围内。偏离指定温度条件会影响临床试验结果的品质和可靠性，并可能导致安全问题和资料不准确。

个人化医疗的兴起

随着治疗越来越针对个别患者的情况，对专业和定製药物的需求不断增加。这种范式转移需要灵活高效的供应链来满足从独特配方到特定患者群体的不同临床实验要求。能够巧妙地调整其供应链和物流策略以适应个人化医疗的复杂性的公司可以利用这种不断变化的形势，促进创新并提高临床试验的成功率。

公众监督与关注

围绕临床试验的负面看法和争议可能会损害公众的信任。道德问题、病人安全或对公司利润的看法等问题可能会引起媒体、监管机构和公众的密切关注。在社群媒体和倡议团体的推动下，公众意识的提高可以放大供应和物流流程中感知到的缺陷的影响。负面看法可能导致监管力度加大、临床实验日程延误以及製药公司和研究机构的声誉受损，从而危及临床试验的整体成功并阻碍医学研究的进展。

COVID-19 的影响：

COVID-19 的疫情对市场产生了重大影响，带来了供应链中断、患者入组延迟以及某些治疗领域需求增加等挑战。封锁、旅行限制和资源重新分配影响了临床实验药物的及时分配，并导致后勤复杂性增加。製药公司和委外研发机构必须快速适应，实施弹性供应链策略和创新，以确保在这个前所未有的时期临床试验的连续性和效率，物流解决方案的重要性凸显。

第三阶段预计将是预测期内最大的部分

第三阶段预计将占据最大份额。临床试验市场的第三阶段是药物、治疗和疗法等医疗干预措施开发和评估的关键阶段。 III 期临床试验非常复杂，需要强大的技术和可靠的临床资源来有效地招募患者、快速推出试验地点并经济有效地管理试验。它被视为临床试验。此外，在第三阶段临床试验中，研究人员仔细收集资料以确认和扩展早期阶段。目的是证明具有统计意义的结果，并将介入措施与标准护理、安慰剂或其他相关比较物进行比较。

预计製药业在预测期内复合年增长率最高

预计製药业在预测期内将以最有效的速度成长。该专业专注于将临床实验药物及时可靠地运送到各个临床试验地点。高效率的供应链物流、温控储存和法规遵循是重要的方面。在该市场运营的公司提供全面的解决方案，以简化临床试验药物的复杂供应流程，以支持新药和治疗方法的开发。

比最大的地区

在估计期间，北美占据了最大的市场占有率。在北美，由于多种因素，包括感染疾病和慢性病患病率的上升、对个体化治疗的需求以及蓬勃发展的製药业的存在，该市场正在扩大。该地区的法规环境也很有利，FDA 在核准和监督临床试验方面发挥关键作用。随着疫苗和治疗研究的不断增加，COVID-19大流行也推动了北美临床试验市场的成长。

复合年增长率最高的地区：

由于患者人数的增加和负担得起的治疗，预计亚太地区在预测期内将出现有益的增长。亚太临床试验市场具有良好的市场开拓潜力。这是由于该地区负担得起的临床试验、生产设施的扩张、支持性的政府法规以及製药业务的扩张。较低的成本、更大的治疗人群、保留临床试验参与者以及监管程序的持续改进是该地区临床试验活动增加的主要驱动力。

免费客製化服务：

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场公司的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 调查来源
    • 主要调查来源
    • 二次调查来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球临床试验供应物流市场：依阶段

  • 第一阶段
  • 第二阶段
  • 第三阶段
  • 第四阶段

第六章全球临床试验供应物流市场：依服务类型

  • 物流/配送
  • 储存/保留
  • 包装、标籤、蒙眼
  • 比较器采购
  • 其他服务类型

第七章全球临床试验供应物流市场：依治疗领域

  • 肿瘤学
  • 神经病学
  • 免疫学
  • 遗传疾病
  • 感染疾病
  • 代谢紊乱
  • 心臟病学
  • 其他治疗领域

第八章全球临床试验供应物流市场：依应用分类

  • 低分子
  • 疫苗
  • 单株抗体
  • 细胞和基因治疗
  • 其他用途

第九章全球临床试验供应物流市场：依最终使用者分类

  • 药品
  • 生物製药
  • 医疗设备
  • 其他最终用户

第十章全球临床试验供应物流市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东/非洲

第十一章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十二章 公司简介

  • Parexel
  • Thermo Fisher Scientific（Patheon）
  • Catalent, Inc.
  • Packaging Coordinators Inc.
  • Almac Group
  • Piramal Pharma Solutions
  • UDG Healthcare
  • DHL
  • FedEx
  • Movianto
Product Code: SMRC24699

According to Stratistics MRC, the Global Clinical Trial Supply & Logistics Market is accounted for $3.9 billion in 2023 and is expected to reach $7.3 billion by 2030 growing at a CAGR of 9.5% during the forecast period. Clinical Trial Supply & Logistics (CTSL) is a specialized field ensuring the efficient and secure movement of medication, equipment, and other vital materials needed for clinical research. It encompasses activities like inventory management, packaging, transportation, customs clearance, and temperature control, ensuring timely delivery to clinical trial sites across the globe. CTSL ensures clinical trials run smoothly, contributing to the development of new drugs and therapies.

Market Dynamics:

Driver:

Increased demand for clinical trials

The increased demand translates to a booming Clinical Trial Supply & Logistics (CTSL) market. As more trials are conducted, the need for secure transport, precise inventory management, and specialized handling of materials like temperature-sensitive drugs becomes crucial. CTSL providers are stepping up to meet this demand by investing in technology, expanding global reach, and offering customized solutions for personalized medicine and patient engagement. Thus, the booming clinical trial landscape directly fuels the growth and innovation within the CTSL market.

Restraint:

Temperature sensitive products

Clinical trials often involve the transportation and storage of temperature-sensitive drugs, vaccines, or biological samples that require specific and controlled conditions to maintain their efficacy and integrity. The challenge lies in ensuring that these products are consistently maintained within the recommended temperature ranges throughout the supply chain, from manufacturing to final delivery. Any deviation from the specified temperature conditions can compromise the quality and reliability of the clinical trial results, leading to potential safety issues and data inaccuracies.

Opportunity:

The rise of personalized medicine

As treatments increasingly target individual patient profiles, the demand for specialized and customized pharmaceuticals escalates. This paradigm shift necessitates a flexible and efficient supply chain to accommodate diverse trial requirements, ranging from unique drug formulations to specific patient populations. Companies that adeptly adapt their supply and logistics strategies to the intricacies of personalized medicine stand to capitalize on this evolving landscape, driving innovation and enhancing clinical trial success.

Threat:

Public scrutiny and concerns

Any negative perception or controversy surrounding these trials can undermine public trust. Issues such as ethical concerns, patient safety, or perceived corporate interests may trigger intense scrutiny from the media, regulatory bodies, and the general public. Heightened public awareness, fueled by social media and advocacy groups, can amplify the impact of any perceived shortcomings in the supply and logistics processes. Negative perceptions can result in increased regulatory scrutiny, delays in trial timelines, and reputational damage for pharmaceutical companies and research organizations, thereby jeopardizing the overall success of clinical trials and hindering advancements in medical research.

COVID-19 Impact:

The COVID-19 pandemic has significantly impacted the market, introducing challenges such as disrupted supply chains, delays in patient enrollment, and increased demand for certain therapeutic areas. Lockdowns, travel restrictions, and resource reallocation have affected the timely distribution of investigational products, leading to logistical complexities. Pharmaceutical companies and contract research organizations have had to adapt rapidly, emphasizing the importance of resilient supply chain strategies and innovative logistics solutions to ensure the continuity and efficiency of clinical trials during these unprecedented times.

The Phase III segment is expected to be the largest during the forecast period

The Phase III segment is estimated to hold the largest share. The Phase 3 segment of the clinical trials market represents a crucial stage in the development and evaluation of medical interventions, such as drugs, treatments, or therapies. Phase III clinical trials are considered complex clinical trials that require both robust technologies and reliable clinical resources to recruit patients efficiently, initiate sites quickly, and provide cost-effective study management. Furthermore, during Phase 3 trials, researchers carefully gather data to confirm and extend the findings from earlier phases. They aim to demonstrate statistically significant results and compare the intervention against standard treatments, placebos, or other relevant comparators.

The pharmaceuticals segment is expected to have the highest CAGR during the forecast period

During the anticipated period, the pharmaceuticals segment is expected to increase at the most effective rate. This specialized sector focuses on ensuring the timely and secure delivery of investigational drugs to various clinical trial sites. Efficient supply chain logistics, temperature-controlled storage, and regulatory compliance are critical aspects. Companies operating in this market provide comprehensive solutions to streamline the complex process of supplying pharmaceuticals for clinical trials, supporting the development of new drugs and therapies.

Region with largest share:

North America commanded the largest market share during the extrapolated period. The market is expanding in North America due to a number of factors, including the rising incidence of infectious and chronic diseases, the demand for personalised treatment, and the existence of a thriving pharmaceutical sector. The regulatory climate in the area is also supportive, with the FDA playing a key role in the approval and supervision of clinical trials. With an increase in vaccine and therapy studies, the COVID-19 pandemic has also fuelled growth in the North American clinical trials market.

Region with highest CAGR:

Asia-Pacific region is expected to witness profitable growth over the projection period, due to the growing patient base and affordable treatments. The clinical trials market has excellent development potential in Asia and the Pacific. This can be attributed to the region's affordable clinical trials, expanding manufacturing facilities, enacting supportive government regulations, and expanding pharmaceutical business. Cost savings, a large treatment population, participant retention in clinical trials, and ongoing regulatory procedural improvements are mostly responsible for the rise of clinical trial activities in the area.

Key players in the market:

Some of the key players in Clinical Trial Supply & Logistics market include Parexel, Thermo Fisher Scientific (Patheon), Catalent, Inc., Packaging Coordinators Inc., Almac Group, Piramal Pharma Solutions, UDG Healthcare, DHL, FedEx and Movianto.

Key Developments:

In October 2023, Piramal Pharma Solutions partnered with an AI-powered platform provider to streamline clinical trial supply chain management. This partnership leverages AI and machine learning to optimize inventory management, route planning, and real-time visibility into the location and status of clinical trial supplies.

In September 2023, Thermo Fisher Scientific (Patheon) acquired a leading European clinical trial logistics company, significantly increasing presence in Europe and expertise in complex trial logistics.

In February 2023, Parexel launched a new expert series, New Medicines, Novel Insights. The series features fresh insights from the company's global, cross-functional experts analyzing drug development trends and offering evidence-based guidance to the biopharmaceutical industry.

Phases Covered:

  • Phase I
  • Phase II
  • Phase III
  • Phase IV

Service Types Covered:

  • Logistics & Distribution
  • Storage & Retention
  • Packaging, Labeling, and Blinding
  • Comparator Sourcing
  • Other Service Types

Therapeutic Areas Covered:

  • Oncology
  • Neurology
  • Immunology
  • Genetic Diseases
  • Infectious Diseases
  • Metabolic Disorders
  • Cardiology
  • Other Therapeutic Areas

Applications Covered:

  • Small Molecules
  • Vaccine
  • Monoclonal Antibodies
  • Cell & Gene Therapy
  • Other Applications

End User Covered:

  • Pharmaceuticals
  • Biologicals
  • Medical Device
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Clinical Trial Supply & Logistics Market, By Phase

  • 5.1 Introduction
  • 5.2 Phase I
  • 5.3 Phase II
  • 5.4 Phase III
  • 5.5 Phase IV

6 Global Clinical Trial Supply & Logistics Market, By Service Type

  • 6.1 Introduction
  • 6.2 Logistics & Distribution
  • 6.3 Storage & Retention
  • 6.4 Packaging, Labeling, and Blinding
  • 6.5 Comparator Sourcing
  • 6.6 Other Service Types

7 Global Clinical Trial Supply & Logistics Market, By Therapeutic Area

  • 7.1 Introduction
  • 7.2 Oncology
  • 7.3 Neurology
  • 7.4 Immunology
  • 7.5 Genetic Diseases
  • 7.6 Infectious Diseases
  • 7.7 Metabolic Disorders
  • 7.8 Cardiology
  • 7.9 Other Therapeutic Areas

8 Global Clinical Trial Supply & Logistics Market, By Application

  • 8.1 Introduction
  • 8.2 Small Molecules
  • 8.3 Vaccine
  • 8.4 Monoclonal Antibodies
  • 8.5 Cell & Gene Therapy
  • 8.6 Other Applications

9 Global Clinical Trial Supply & Logistics Market, By End User

  • 9.1 Introduction
  • 9.2 Pharmaceuticals
  • 9.3 Biologicals
  • 9.4 Medical Device
  • 9.5 Other End Users

10 Global Clinical Trial Supply & Logistics Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Parexel
  • 12.2 Thermo Fisher Scientific (Patheon)
  • 12.3 Catalent, Inc.
  • 12.4 Packaging Coordinators Inc.
  • 12.5 Almac Group
  • 12.6 Piramal Pharma Solutions
  • 12.7 UDG Healthcare
  • 12.8 DHL
  • 12.9 FedEx
  • 12.10 Movianto

List of Tables

  • Table 1 Global Clinical Trial Supply & Logistics Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Clinical Trial Supply & Logistics Market Outlook, By Phase (2021-2030) ($MN)
  • Table 3 Global Clinical Trial Supply & Logistics Market Outlook, By Phase I (2021-2030) ($MN)
  • Table 4 Global Clinical Trial Supply & Logistics Market Outlook, By Phase II (2021-2030) ($MN)
  • Table 5 Global Clinical Trial Supply & Logistics Market Outlook, By Phase III (2021-2030) ($MN)
  • Table 6 Global Clinical Trial Supply & Logistics Market Outlook, By Phase IV (2021-2030) ($MN)
  • Table 7 Global Clinical Trial Supply & Logistics Market Outlook, By Service Type (2021-2030) ($MN)
  • Table 8 Global Clinical Trial Supply & Logistics Market Outlook, By Logistics & Distribution (2021-2030) ($MN)
  • Table 9 Global Clinical Trial Supply & Logistics Market Outlook, By Storage & Retention (2021-2030) ($MN)
  • Table 10 Global Clinical Trial Supply & Logistics Market Outlook, By Packaging, Labeling, and Blinding (2021-2030) ($MN)
  • Table 11 Global Clinical Trial Supply & Logistics Market Outlook, By Comparator Sourcing (2021-2030) ($MN)
  • Table 12 Global Clinical Trial Supply & Logistics Market Outlook, By Other Service Types (2021-2030) ($MN)
  • Table 13 Global Clinical Trial Supply & Logistics Market Outlook, By Therapeutic Area (2021-2030) ($MN)
  • Table 14 Global Clinical Trial Supply & Logistics Market Outlook, By Oncology (2021-2030) ($MN)
  • Table 15 Global Clinical Trial Supply & Logistics Market Outlook, By Neurology (2021-2030) ($MN)
  • Table 16 Global Clinical Trial Supply & Logistics Market Outlook, By Immunology (2021-2030) ($MN)
  • Table 17 Global Clinical Trial Supply & Logistics Market Outlook, By Genetic Diseases (2021-2030) ($MN)
  • Table 18 Global Clinical Trial Supply & Logistics Market Outlook, By Infectious Diseases (2021-2030) ($MN)
  • Table 19 Global Clinical Trial Supply & Logistics Market Outlook, By Metabolic Disorders (2021-2030) ($MN)
  • Table 20 Global Clinical Trial Supply & Logistics Market Outlook, By Cardiology (2021-2030) ($MN)
  • Table 21 Global Clinical Trial Supply & Logistics Market Outlook, By Other Therapeutic Areas (2021-2030) ($MN)
  • Table 22 Global Clinical Trial Supply & Logistics Market Outlook, By Application (2021-2030) ($MN)
  • Table 23 Global Clinical Trial Supply & Logistics Market Outlook, By Small Molecules (2021-2030) ($MN)
  • Table 24 Global Clinical Trial Supply & Logistics Market Outlook, By Vaccine (2021-2030) ($MN)
  • Table 25 Global Clinical Trial Supply & Logistics Market Outlook, By Monoclonal Antibodies (2021-2030) ($MN)
  • Table 26 Global Clinical Trial Supply & Logistics Market Outlook, By Cell & Gene Therapy (2021-2030) ($MN)
  • Table 27 Global Clinical Trial Supply & Logistics Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 28 Global Clinical Trial Supply & Logistics Market Outlook, By End User (2021-2030) ($MN)
  • Table 29 Global Clinical Trial Supply & Logistics Market Outlook, By Pharmaceuticals (2021-2030) ($MN)
  • Table 30 Global Clinical Trial Supply & Logistics Market Outlook, By Biologicals (2021-2030) ($MN)
  • Table 31 Global Clinical Trial Supply & Logistics Market Outlook, By Medical Device (2021-2030) ($MN)
  • Table 32 Global Clinical Trial Supply & Logistics Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.